Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2019-08-13 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于2019年半年度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (407 characters) from Guangzhou Yangpu Medical Technology Co., Ltd. It states that the 2019 semi-annual report and its summary have been published on the designated disclosure website. The text does not contain the actual semi-annual report or substantive financial data, but rather directs investors to where the report can be found. This fits the pattern of a Report Publication Announcement (RPA) rather than the report itself (which would be an Interim/Quarterly Report).
2019-08-13 Chinese
关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding a change in accounting policies. It references a regulatory notice from the Ministry of Finance of China (财会[2019]6号) about revisions to the financial statement formats for 2019. The document details the reasons for the change, the approval process by the board and supervisory committee, and the impact on financial statement presentation. It explicitly states that the change does not affect net assets or net profit and is in compliance with relevant laws and regulations. The document is relatively short (2327 characters) and serves as a formal announcement of the accounting policy change rather than a full financial report or audit report. It does not contain actual financial statements or detailed financial data but rather the decision and rationale behind the accounting policy change. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-08-13 Chinese
关于使用闲置资金进行银行结构性存款的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Guangzhou Yangpu Medical Technology Co., Ltd. regarding the use of idle funds to conduct bank structured deposits. It details the board meeting resolutions, purpose, amount, duration, risk control measures, and impact on daily operations. The document is an announcement of a financing or capital management activity involving the company's funds, specifically about using idle funds for structured deposits to improve fund utilization and reduce financial costs. It is not a full financial report, audit, or earnings release, nor is it a regulatory filing or voting result. The content fits best under Capital/Financing Update (CAP) as it relates to the company's capital management and financing activities.
2019-08-13 Chinese
关于限售股份解禁并上市流通的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the lifting of restrictions on certain shares and their listing for circulation. It details the number of shares to be unlocked, the background of these shares, commitments by shareholders, and the impact on share capital structure. The document references regulatory approvals and compliance with securities regulations but does not contain financial statements or detailed financial performance data. It is primarily an announcement about share unlocking and listing circulation, not a financial report or earnings release. Given the content and length (4041 characters), it fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about share restrictions and listing, not a full report or financial statement.
2019-08-05 Chinese
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate issued by a regulatory authority (Guangdong Provincial Drug Administration). It details the product name, registration number, validity period, classification, and intended use. The document is short (899 characters) and serves as a formal notification to investors about a regulatory approval event, not a financial report or detailed operational report. There is no financial data, no discussion of financial results, no management commentary on earnings, no voting results, no capital changes, and no legal proceedings. It is an announcement of a regulatory milestone relevant to the company's product portfolio and market competitiveness. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-07-31 Chinese
关于第一期员工持股计划存续期即将届满的补充公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the status of its first employee stock ownership plan nearing its expiration. It provides details about the stock holdings under the plan, compliance with market rules, and disclosure obligations. The document is short (705 characters) and serves as a supplemental announcement updating investors on the employee stock plan status. It does not contain financial statements, audit information, or detailed financial data. It is not a report but an announcement related to shareholding and stock plans. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-07-15 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.